SOMAÍ Pharmaceuticals and Canify Announce Their Partnership to Introduce a Cannabinoid-Based Product Line in Germany
SOMAÍ Pharmaceuticals Unipessoal LDA ("SOMAÍ"), an EU-GMP European pharmaceutical and biotech company distributing cannabinoid-containing pharmaceuticals globally, announces a landmark three-year marketing & distribution agreement with Canify AG ("Canify"), a licensed pharmaceutical company focussing on medical cannabis.